Last update: May 2016
For more information, please contact: firstname.lastname@example.org
Overview of BiosimilarNews.com
- BiosimilarNews.com is a popular website that covers biosimilars (similar biotherapeutic products, follow-on biologics, subsequent entry biologics, similar biopharmaceuticals).
- This media kit describes opportunities for advertisers to reach this unique, valuable audience.
Audience & Demographics
BiosimilarNews.com audience: BiosimilarNews.com targets biopharmaceutical/biotechnology industry professionals, healthcare providers like physicians and pharmacists and also professionals from government, research, academic and scientific institutes. Legal and patent companies, industry organizations, generic manufacturers and even CROs follow this website regularly.
BiosimilarNews.com has seen traffic grow considerably since its launch in August 2011. Visitors to BiosimilarNews.com are highly targeted, and arrive mainly via browser bookmarks, targeted search engine queries, social media interactions, and highly relevant inbound links. In short, our website is uniquely positioned to offer an audience that is receptive to your advertising message.
What we achieved:
- BiosimilarNews.com hosts over 650 articles since its launch in August 2011
- BiosimilarNews.com has been a reputable Media Partner for several global events till date
- Bi-monthly newsletter highest open rate: 52.2% (industry average 16.1%)
- Email blast (advertiser) highest open rate: 40.2%
The following information describes the size and scale of BiosimilarNews.com‘s audience. Here is a breakdown of BiosimilarNews.com‘s website traffic.
Social Media Metrics:
Here is a breakdown of BiosimilarNews.com‘s presence on major social media platforms.
|Social Media Followers/Subscribers|
|LinkedIn Contacts&Group Members||1382|
Here is a breakdown of devices that are used to reach BiosimilarNews.com.
Here is a breakdown of the demographics of BiosimilarNews.com‘s audience.
|World Wide access within last 30 days|
The above traffic and demographic information was sourced via Alexa, Twitter, LinkedIn and Google Analytics on 25th of May 2016.
Rates & Opportunities
BiosimilarNews.com offers numerous advertising opportunities for advertisers to reach this valuable, targeted audience.
Standard Advertising Opportunities
Ad prices are listed in flat rate and should be paid through PayPal. Our site refers to the Interactive Advertising Bureau for standard ad sizes and file size limits. Please refer to http://www.iab.net/guidelines/508676/508767/displayguidelines for additional information on ad specifications.
|Other Ad Unit||300×600||Flat||$300/w|
In addition to standard website banner advertising, BiosimilarNews.com also offers the following:
- Eblast sponsorship: You can sponsor our bi-monthly newsletter for certain period of terms. Please see a copy of our recent eblasts here and please send your sponsorship offer to email@example.com
- Stand alone eblast: You can also reach our subscribers directly. The html version should be provided by the advertiser and must be approved by BiosimilarNews.com. Please send your offer to firstname.lastname@example.org
- LinkedIn Group: Discussions, Promotions and Job Offers can be published to our LinkedIn Group. Please send your offer to email@example.com
These additional opportunities allow you to reach our targeted audience through non-traditional media. Contact us for additional information on how you can take advantage of these unique opportunities.
For more information, please contact: firstname.lastname@example.org. You can generally expect a response within 24 hours.